Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

Pasteurization at 63°C and 72°C effectively inactivates influenza A viruses in milk, ensuring its safety for human ...

A recent study published in Nature Communications by researchers at the National Institute of Allergy and Infectious Diseases (NIAID) and collaborators evaluated a replicating RNA (repRNA) vaccine ...

Guam Memorial Hospital Administrator Lilian Perez-Posadas said there are no suspected cases of norovirus or H5N1 infections on the island. “If the [Emergency Room] doctor on duty suspects a ...

The mRNA vaccine against avian influenza presents several advantages and disadvantages: Advantages: Rapid Development and Production; Non-Infectious Nature; Strong Immune Response; Adaptability to ...

The US Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS) today confirmed more H5N1 avian ...

Rhode Island Hospital at Brown University Health will receive $1 million to demonstrate proof of concept for a test that uses ...

FDA issues proposed rule on front-of-package nutrition labeling. The FDA has released its proposed rule on front-of-package nutrition labeling ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

CEO Larry Ellison’s claims that artificial intelligence (AI) could help develop messenger RNA-based (mRNA) vaccines to cure ...

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

Consumers are clear in this new survey that they do not want to consume cow’s milk affected by bird flu virus, even if the ...